ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1329

Prevalence of Bone Fragility on DXA and CT in Patients with Obesity

Marion Halin1, Edem Allado1, Didier Quilliot1, Eliane Albuisson1, Isabelle Chary-Valckenaere1, Damien Loeuille1, Laurent Brunaud1 and Marine FAUNY2, 1Nancy University Hospital, Vandoeuvre, France, 2Nancy University Hospital, Toul, France

Meeting: ACR Convergence 2022

Keywords: Bone density, Dual energy x-ray absorptiometry (DEXA), Imaging, obesity, osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Primary objective was to evaluate bone fragility prevalence on dual X-ray absorptiometry (DXA) and on computed tomography (CT), in patients with severe obesity. Secondary objective was to evaluate the risk factors for bone fragility.

Methods: This monocentric study was conducted in patients with grade 2 and 3 obesity, who performed a CT and/or a DXA within two years. Bone mineral density (BMD) and T-score were studied on DXA and scanographic bone attenuation coefficient of L1 (SBAC-L1) was measured on CT. Bone fragility was defined by T-score≤-2.5 standard deviation (SD) and an SBAC-L1≤145 Hounsfield units (HU). The diagnosis of osteoporosis was retained for a T-score ≤ − 2.5 SD and osteopenia for -2.5 SD < T-score ≤ -1 SD.

Results: Among 1386 patients included, 1013 had performed both DXA and CT within less than 2 years. Mean age was 48.4 years (±11.4), 77.6% were women and mean BMI was 45.6 kg/m² (±6.7). Eight patients (0.8%) had osteoporosis on at least one site and 119 (11.7%) had osteopenia. Mean SBAC-L1 was 192.3 HU (±52.4); 163 patients (16.1%) were under the fracture threshold of 145HU. Older age (OR[CI95]=1.1 [1.08-1.16]), lower BMD on femoral neck and spine (OR[CI95]=0.04[0.005-0.33] and OR[CI95]=0.001[0.0001-0.008], respectively), and higher lean mass (OR[CI95]=1.1[1.03-1.13]) were significantly associated with an SBAC-L1≤145HU in multivariate analysis. BMI was a protective factor (OR[CI95]=0.9[0.82-0.92].

Conclusion: About 16% of patients with grade 2 and 3 obesity were under the SBAC-L1 fracture threshold, when less than 1% were classified as osteoporotic on DXA. Risk factors for an SBAC-L1≤145HU were older age, lower BMI, lower BMD on femoral neck or spine and higher lean mass.


Disclosures: M. Halin, None; E. Allado, None; D. Quilliot, None; E. Albuisson, None; I. Chary-Valckenaere, None; D. Loeuille, None; L. Brunaud, None; M. FAUNY, None.

To cite this abstract in AMA style:

Halin M, Allado E, Quilliot D, Albuisson E, Chary-Valckenaere I, Loeuille D, Brunaud L, FAUNY M. Prevalence of Bone Fragility on DXA and CT in Patients with Obesity [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/prevalence-of-bone-fragility-on-dxa-and-ct-in-patients-with-obesity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-bone-fragility-on-dxa-and-ct-in-patients-with-obesity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology